Viewing Study NCT04286958


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:01 PM
Study NCT ID: NCT04286958
Status: UNKNOWN
Last Update Posted: 2021-12-10
First Post: 2020-02-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC
Sponsor: Hebei Medical University Fourth Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module